Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 312

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 312
---

is due upon the earlier of the consummation of this offering or March 31, 2025. In addition, upon maturity, the Company will pay to
our Chief Executive Officer an aggregate risk premium equal to 30% of the loan amount (or approximately $35,100 plus VAT). If a
registration statement for an initial public offering is made effective no later than March 31, 2025, then the maturity date will be
extended to June 30, 2025. In addition, pursuant to the December 2024 Loan Agreement, upon the consummation of this offering the
Company will issue warrants, or the CEO Loan Warrants, exercisable for a period of three years from the date of the issuance, to
purchase such number of Ordinary Shares equal to two times the respective loan amount divided by 75% of the lowest price per
Ordinary Share during the first five trading days following the consummation of this offering, at an exercise price equal to 75% of
the lowest price per Ordinary Share during the first five trading days following the consummation of this offering. The outstanding
debt will become immediately due and payable upon an event of default (as defined in the December 2024 Loan Agreement), which shall
be deemed to have occurred upon certain circumstances as detailed in the December 2024 Loan Agreement. On March 31, 2025, we and our
Chief Executive Officer entered an amendment to the December 2024 Loan Agreement to extend the maturity date until the earlier of
August 31, 2025, and during September 2025, the December 2024 Loan Agreement was further extended to November 30, 2025, or the
consummation of an IPO. On July 1, 2025, we entered into an amendment to the December 2024 Loan Agreement such that our Chief
Executive Officer shall be granted warrants to purchase up to 55,224 Ordinary Shares following the consummation of this public
offering.

In April 2025, we
entered into bridge loan agreements, or the 2025 Loan Agreements, pursuant to which we obtained a bridge loans in the aggregate
amount of $200,000 from certain lenders, including certain related parties. The loans pursuant to the 2025 Loan Agreements bear
interest at a rate of 8% per annum until maturity. Pursuant to the terms of the 2025 Loan Agreements, we also agreed to pay the